hrp0082p3-d2-777 | Fat Metabolism & Obesity (1) | ESPE2014

The Interaction of Exophtalmos with Obesity in Turkish Children and Adolescents

Cicek Betul , Ozturk Ahmet , Mazicioglu Mumtaz , Kurtoglu Selim , Kara Tuncay , Hatipoglu Nihal

Background: Many clinicians are aware of the systemic complications of obesity, however there are few studies on the effect of the ocular manifestations of obesity. The ocular complications of obesity include diabetic retinopathy, high intraocular pressure, cataracts, macular degeneration, floppy lid syndrome, pseudotumor cerebri, and exophthalmos. All of these complications can have serious consequences to the individualÂ’s ocular health and visual well-being.<p class...

hrp0082p3-d3-804 | Gonads and Gynaecology | ESPE2014

Complete Blood Count Parameters in Girls with Polycystic Ovary Syndrome

Ucakturk Ahmet , Demirel Fatma , Tayfun Meltem , Tepe Derya , Elmaogullari Selin , Kara Ozlem

Background: Polycystic ovary syndrome (PCOS) is characterized by ovulatory dysfunction and excess androgen secretion. Androgens may affect bone marrow cells via androgen receptor which expressed in the bone marrow. Also it is known that especially testosterone increases hemoglobin and hematocrit concentrations.Objective and hypotheses: Our aim in this study is to describe the relation between hyperandrogenism and complete blood count (CBC) parameters in ...

hrp0084p3-758 | Diabetes | ESPE2015

A Case of Tacrolimus Related Posttranslated Diabetes Mellitus (PTDM)

Keskin Mehmet , Karaoglan Murat , Kara Mehtap Akbalik , Buyukcelik Mithat , Keskin Ozlem

Background: Tacrolimus is highly potent immunosuppressant agent. Despite it is quite prophylactic effect on renal allogreft rejection, the most marked side effect of tacrolimus is lead to posttranslated diabetes mellitus. There are some predictive risk factors which are determined on development of tacrolimus related diabetes mellitus: Advanced age, familial history, genetic factors, ethnicity, impaired glucose tolerance or metabolic syndrome in pre-transplantation period, obe...

hrp0097rfc10.3 | Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) &amp; Multisystem endocrine disorders | ESPE2023

Non-coding Variants in HK1 Account for 5% of Cases of Congenital Hyperinsulinism Without an Identified Genetic Cause

Rosenfeld Elizabeth , E. Boodhansingh Kara , A. Stanley Charles , Ganguly Arupa , D. De Leon Diva

Background: The genetic etiology of non-syndromic HI remains unknown in over 20% of all cases, and over 50% of diazoxide-responsive cases. Non-coding variants in HK1 have been suggested to cause HI by linkage-analysis (Pinney et al., 2008). More recently, variants within a regulatory region of HK1 intron 2 were reported in 17 individuals with HI (Wakeling et al., 2022). These variants have been proposed to cause HI by disrup...

hrp0098rfc12.3 | Thyroid | ESPE2024

Mechanisms and natural history of pituitary resistance to exogenous thyroxine in children with congenital hypothyroidism

Mammadova Jamala , Kara Cengiz , İzci Güllü Elif , Akın Leyla , Aydın Murat

Background: Pituitary resistance to exogenous thyroxine (RETH) refers to persistently elevated serum TSH levels despite high/normal T4 concentrations in levothyroxine-treated patients. The underlying mechanisms and natural history of RETH in children with congenital hypothyroidism (CH) are not well known.Objective: We aimed to describe the possible mechanisms and natural history of RETH in children with CH.<p class="...

hrp0095p1-332 | Growth and Syndromes | ESPE2022

Growth Hormone Therapy Experience in a Patient with Hypotonia Cystinuria Syndrome

Sarıkaya Emre , Berber Uğur , Gök Ebru , Kara Leyla , Gül Şiraz Ülkü , Hatipoğlu Nihal

Background: Hypotonia-Cystinuria Syndrome (HCS) is a rare autosomal recessive disease characterized by generalized hypotonia, nephrolithiasis, short stature, minor facial dysmorphism, hyperphagia, and rapid weight gain in late childhood. Microdeletion can be detected in part of the SLC3A1 and PREPL genes in these cases. Growth hormone deficiency is rarely seen in these patients and adequate growth can be achieved with growth hormone therapy.<p class="abste...

hrp0095p2-208 | Multisystem Endocrine Disorders | ESPE2022

Precocious puberty before and after the COVID-19 pandemic

Gök Ebru , Sarıkaya Emre , Kara Leyla , Berber Uğur , Gül Şiraz Ülkü , Hatipoğlu Nihal

Introduction: A novel coronavirus defined as coronavirus disease 2019 (COVID-19) was first detected in China at the end of 2019 and spread rapidly all over the world. As the covid 19 pandemic has led to changes in life all over the world, the prognosis of diseases have also been affected. This study presents how early puberty has been affected during the pandemic period.Method: A total of 210 subjects; 113 individuals (9...

hrp0089p3-p021 | Adrenals and HPA Axis P3 | ESPE2018

Presenting Features, Clinical Characteristics and Follow up of Familial Isolated Glucocorticoid Deficiency (FGD) due to Mutations in MC2R and MRAP Genes

Ozbek Mehmet Nuri , Karaşin Nezehat Doğan , Demirbilek Huseyin , Demiral Meliha , Baran Rıza Taner , Guran Tulay

Objectives: Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterized with isolated glucocorticoid deficiency. Melanocortin receptor 2 (MC2R) mediates the functions of adrenocorticotropic hormone (ACTH) in the adrenal cortex. MC2R accessory protein (MRAP), a transmembrane protein, involves in the trafficking of MC2R to the cell surface. Mutations in MC2R and MRAP genes cause FGD type 1 and 2. Herein, we ev...

hrp0098p1-258 | Growth and Syndromes 3 | ESPE2024

First Real-Life Data on the Use of Long-Acting Growth Hormone Somatrogon in Türkiye

Kara Cengiz , Çatlı Gönül , Çayır Atilla , Ercan Oya , Özen Samim , Darcan Şükran

Background: The long-acting growth hormone (LAGH) somatrogon has been found to be as effective and safe as daily somatotropin in the treatment of children with GH deficiency (GHD). Somatrogon administered once weekly has the potential to improve treatment adherence and height prognosis.Objective: We aimed to evaluate the first real-life data on somatrogon therapy, which was launched in Türkiye in October 2023.<p...

hrp0095p1-198 | Thyroid | ESPE2022

FT3:FT4 ratio be used to predict relapse and remission? Single Centre Experience

Kara Leyla , Çiçek Dilek , Sarıkaya Emre , Gök Ebru , Berber Uğur , Gül Şiraz Ülkü , Kurtoğlu Selim , Kendirci Mustafa , Hatipoğlu Nihal

Introduction: Graves’ Disease (GD) is autoimmune hyperthyroidism occurring mostly in adolescent girls. The main pathogenic role of the disease is attributed to TSH receptor antibodies (TRAb), which stimulate the thyroid gland to increase the production of the most active thyroid hormone- triiodothyronine (T3). High levels of TRAb and a large goitre size are commonly known as poor prognostic factors for the disease and are used to predict relapse.<p c...